CT News and Research RSS Feed - CT News and Research

Oncolytics completes patient enrollment in phase II metastatic pancreatic cancer study

Oncolytics completes patient enrollment in phase II metastatic pancreatic cancer study

Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045). [More]

Review proposes imaging tools to help visualize peripheral nerve regeneration process

Researchers at the Institute of Polymer Science and Engineering in Taipei, Taiwan, led by Dr. Hsu have been involved in peripheral nerve regeneration research for more than ten years. Dr. Hsu and her team have focused on development of polymeric nerve conduits to facilitate peripheral nerve regeneration. [More]

Eligibility for subsidies not properly checked, audit finds

The HHS inspector general issues two reports concluding the federal health marketplace and some state exchanges had inadequate safeguards to stop people who were ineligible from getting tax credits to help pay for premiums. [More]
Justices rule home health care aides can't be forced to pay union dues

Justices rule home health care aides can't be forced to pay union dues

The high court's ruling will make it more difficult for unions in some states to continue organizing the aides, a rapidly growing segment of the workforce. [More]
Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA. [More]
NCCN Policy Summit to address impact of health care reform on academic oncology practice

NCCN Policy Summit to address impact of health care reform on academic oncology practice

On July 10, 2014, the National Comprehensive Cancer Network® (NCCN®) will host the NCCN Policy Summit: The Impact of Health Care Reform on Academic Oncology Practice, at The Westin Arlington Gateway in Arlington, Virginia, as part of the NCCN Oncology Policy Program. [More]
CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis. [More]

Inaccurate doctor lists hurt access for low-income Californians

Meanwhile, confusion over limited providers also has led to unforeseen bills for enrollees in private plans in California, reports The Los Angeles Times. Other stories look at the growing number of insurers who want to participate in the online marketplaces and how 19 states have passed laws restricting the workers who help consumers sign up, despite a new federal rule eliminating many such restrictions. [More]
Genetic variants alter chance of sunitinib dose reduction

Genetic variants alter chance of sunitinib dose reduction

Scientists have identified genetic variants that reduce the likelihood of sunitinib dose reduction in patients with metastatic renal cell carcinoma. [More]
Phase III TAS-102 study for metastatic colorectal cancer shows improved survival

Phase III TAS-102 study for metastatic colorectal cancer shows improved survival

The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona. [More]
BRI to present clinical-stage product data at International Symposium on Pediatric Neuro-Oncology

BRI to present clinical-stage product data at International Symposium on Pediatric Neuro-Oncology

The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal®) and Antineoplaston AS2-1 injections (Astugenal®), at the 16th International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014. [More]
Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of concern. [More]
Bill would bar Medicare advantage plans from dropping doctors mid-year

Bill would bar Medicare advantage plans from dropping doctors mid-year

The proposal, introduced by Democrats in the House and Senate, would require insurers to finalize their doctor networks 60 days before autumn enrollment begins. [More]

Patients kept in the dark on costs of tests, treatments

The CT Mirror examines the difficulties patients face when trying to comparison shop or simply figure out how much they might have to spend on medical treatments. [More]
CHEO, ONF jointly launch first comprehensive pediatric concussion guidelines

CHEO, ONF jointly launch first comprehensive pediatric concussion guidelines

Pediatric emergency medicine researchers at the Children's Hospital of Eastern Ontario together with the Ontario Neurotrauma Foundation today launch the first comprehensive pediatric concussion guidelines. [More]
Addition of tomosynthesis to digital mammography increases cancer detection rate

Addition of tomosynthesis to digital mammography increases cancer detection rate

The addition of tomosynthesis, a 3-dimensional breast imaging technique, to digital mammography in more than 170,000 examinations was associated with a decrease in the proportion of patients called back for additional imaging and an increase in the cancer detection rate, according to a study in the June 25 issue of JAMA. [More]
Study measures radiation exposure for children with heart disease

Study measures radiation exposure for children with heart disease

Complex heart imaging can increase cancer risks for children throughout their lifetime, according to a new study co-authored by Le Bonheur Cardiologist Jason Johnson, MD, MHS. The study, which appears in the June 9, 2014 issue of the American Heart Association's journal Circulation, is the first in which researchers quantified cumulative radiation doses in pediatric heart patients and predicted lifetime cancer risks based on the types of exposures. [More]
Novel technology serves as "flight simulator" for neurosurgeons

Novel technology serves as "flight simulator" for neurosurgeons

NYU Langone Medical Center is now using a novel technology that serves as a "flight simulator" for neurosurgeons, allowing them to rehearse complicated brain surgeries before making an actual incision on a patient. [More]
Patients continue to lose bone at least 2 years after bariatric surgery, shows study

Patients continue to lose bone at least 2 years after bariatric surgery, shows study

A new study shows that for at least two years after bariatric surgery, patients continue to lose bone, even after their weight stabilizes. [More]

Chicago hospitals see little change in ER visits; Calif. probes Anthem's provider lists

The Chicago Sun-Times examines the health law's effect on local emergency rooms, while the Los Angeles Times reports that state officials are investigating whether Anthem Blue Cross and Blue Shield of California violated state law by posting inaccurate provider lists. [More]